MEDS Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jan 18, 2018)
Marijuana Effective Drug Studies Act of 2018 or the MEDS Act
This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research involving marijuana and the commercial production of drugs made from marijuana.
Specifically, the bill requires the Drug Enforcement Administration to register manufacturers and distributors to supply marijuana: (1) for use in research, and (2) for the commercial production of approved drugs containing or derived from marijuana.
What just happenedJan 24, 2018
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Who’s behind it
- Introduced in HouseJan 18, 2018
- Jan 24, 2018Committee
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Crime and Federal Government Surveillance Subcommittee - Jan 19, 2018Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jan 18, 2018IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Judiciary Committee - Jan 18, 2018IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jan 18, 2018IntroReferralIntro-H
Introduced in House
- Jan 18, 2018IntroReferral1000
Introduced in House